Mammary carcinoma model: Correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density

Radiology

Volumn 198, Issue 3, 1996, Pages 813-818

  Van Dijke, Cornells F ^a,c   Brasch, Robert C ^a   Roberts, Timothy P L ^a   Weidner, Noel ^b   Mathur, Ashwini ^a   Shames, David M ^a   Mann, Jeffry S ^a   Demsar, Franci ^a   Lang, Philipp ^a   Schwickert, Heidi C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Breast neoplasms, MR; Gadolinium; Magnetic resonance (MR), contrast enhancement; Neoplasms, blood supply

Indexed keywords

GADOLINIUM PENTETATE ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CAPILLARY DENSITY; CAPILLARY PERMEABILITY; COMPARTMENT MODEL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA VOLUME; PRIORITY JOURNAL; RAT; TUMOR MODEL; TUMOR VASCULARIZATION;

EID: 13344269679     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.198.3.8628876     Document Type: Article

References (38)

1. Folkman J. Introduction: angiogenesis and cancer. Semin Cancer Biol 1992; 3: 47-48.
2. Folkman J. What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Inst 1990; 82:4-6.
3. Gasparini G, Harris A. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 1995; 13:765-782.
4. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235:442-447.
5. Kim K, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 1993; 362:841-844.
6. Dvorak H, Brown L, Detman M, Dvorak A. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146:1029-1039.
7. Liotta LA, Kleinerman J, Saidel GM. Quantitative relationships of intravascular tumor cells, tumor vessels and pulmonary metastases following tumor implantation. Cancer Res 1974; 34:997-1004.
8. Weidner N. Intratumoral microvascular density as a prognostic factor in cancer. Am J Pathol 1995; 147:9-19.
9. Brem S, Cotran R, Folkman J. Tumor angiogenesis: a quantitative method for histologie grading. J Natl Cancer Inst 1972; 48: 347-356.
10. Revesz I. Vascular density in relation to outcome of radiation therapy: a review. Int J Radiat Biol 1991; 60:179-182.
11. Weidner N, Semple J, Welch W, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
12. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992; 84:1875-1887.
13. Bosari S, Lee A, DeLellis R. Microvessel quantification and prognosis in invasive breast carcinoma. Hum Pathol 1992; 23: 755-761.
14. Horak E, Leek R, Klenk N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992; 340:1120-1124.
15. Macchiarini P, Fontaini G, Hardin M. Relation of neovasculature to metastasis of non-small-cell lung cancer. Lancet 1992; 340:145-146.
16. Wakui S, Furusato M, Itoh T. Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol 1992; 168:257-262.
17. Dvorak H, Nagy J, Dvorak J, Dvorak A. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 1988; 133:95-109.
18. Ackerman N, Hechmer P. Studies on the capillary permeability of experimental liver metastases. Surg Gynecol Obstet 1978; 146: 884-888.
19. Heuser L, Miller F. Differential macromolecular leakage from the vasculature of tumors. Cancer 1986; 57:461-464.
20. Gerlowski LE, Jain RK. Microvascular permeability of normal and neoplastic tissues. Microvasc Res 1986; 31:288-305.
21. Kuwatsuru R, Shames D, Mühler A, et al. Quantification of tissue plasma volume in the rat by contrast-enhanced magnetic resonance imaging. Magn Reson Med 1993; 30:76-81.
22. Shames D, Kuwatsuru R, Vexler V, Muehler A, Brasch R. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative non-invasive technique. Magn Reson Med 1993; 29:616-622.
23. Cohen F, Kuwatsuru R, Shames D, et al. Contrast enhanced MRI estimation of altered capillary permeability in experimental mammary carcinomas following x-irradiation. Invest Radiol 1995; 29:970-977.
24. Schwickert H, Stiskal M, Roberts T, et al. Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy. Radiology 198:893-898.
25. Hilf R, Freeman J, Michel I, Borman A. Characterization of a transplantable lactating mammary tumor. Cancer Res 1964; 24: 812-822.
26. Bogden A. Therapy in experimental breast cancer models, In: McGuire A, ed. Breast cancer. New York, NY: Plenum Medical, 1989; 283-336.
27. Ogan MD, Schmiedl U, Moseley ME, Grodd W, Paajanen H, Brasch RC. Albumin labeled with Gd-DTPA: an intravascular contrast enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest Radiol 1987; 22:665-671.
28. Schmiedl U, Ogan MD, Paajanen H, et al. Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies. Radiology 1987; 162:205-210.
29. Brasch R. Rationale and applications for macromolecular Gd-based contrast agents. In: Workshop on contrast-enhanced magnetic resonance. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1991; 163-169.
30. Renkin EM. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 1959; 197: 1205-1210.
31. Crone C. The permeability of capillaries in various organs determined by the use of the "indicator diffusion" method. Acta Physiol Scand 1963; 58:292-305.
32. Rayston P, Thompson SG. Comparing non-nerted regression models. Biometrics 1995; 51:114-127.
33. Papadimitriou JM, Woods AE. Structural and functional characteristics of the microcirculation in neoplasms. J Pathol 1975; 116:65-72.
34. Folkman J. Angiogenesis and breast cancer. J Clin Oncol 1994; 12:441-443.
35. Dvorak H, Sioussat R, LFB, Berse B. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med 1991; 174:1275-1278.
36. Reimer P, Weissleder R, Nickeleit V, Brady TJ. Animal models for magnetic resonance imaging research of the liver. Invest Radiol 1992; 27:390-393.
37. Russell H, Freeman JJ, Michel I, Borman A. Characterization of a transplantable lactating mammary tumor: endocrinological, morphological and biochemical aspects. Cancer Res 1964; 24:812-823.
38. McGuire WL. Factors influencing metastasis of breast cancer, In: McGuire WL, ed. Breast cancer. San Antonio, Tex: Plenum Medical Book, 1979; 1-25.